New Fly’s Eye-Inspired Smartglasses Offer Vision Correction
At CES 2025, Soliddd Corp. introduced its SolidddVision smartglasses, a new technology aimed at addressing vision loss caused by macular degeneration.
In a Rush? Here are the Quick Facts!
- The technology uses unique lens arrays to project multiple images onto the retina.
- AI software adjusts images, improving vision clarity for individuals with macular degeneration.
- Clinical trials show a 50% improvement in reading ability for some patients.
The device is designed to offer a potential solution for individuals experiencing central vision impairment, a condition affecting millions globally.
The smartglasses feature a unique optical system that projects multiple images to the retina using a specialized lens array. This lens, which resembles a fly’s eye, directs separate images to undamaged areas of the retina, allowing the brain to combine them into a single, focused image.
This process, called stereopsis, enables users to experience a more natural visual field, despite the presence of macular degeneration.
Soliddd’s technology, which has been in development for over a decade, uses parallel-ray light field optics and AI software to deliver this correction. The device captures video through two forward-facing cameras, while two inward-facing cameras track the user’s gaze and map the eye’s interior for precise fitting and adjustment.
The software then processes the images, addressing optical issues like chromatic aberration, and sends the adjusted visuals to displays behind the lenses.
In beta testing, the SolidddVision smartglasses have shown promise in improving the visual acuity of patients with macular degeneration. A clinical study conducted by the Lighthouse Guild demonstrated improvements in reading ability among participants, with many showing a 50% or greater improvement in vision.
The technology has received support from medical professionals in the field, including ophthalmologists and vision rehabilitation specialists, who have observed positive outcomes in user trials. While the product is still in its beta phase, the company aims to bring the device to market following additional patient testing in 2025.
Megan Lisenby, one of the participants who tested the glasses, stated, “Since the age of 19, I’ve lived with a black, empty smudge in the center of my vision due to central cone dystrophy. When I tried the SolidddVision technology, for the first time in almost 30 years, that smudge disappeared and was replaced by an actual image.”
Leave a Comment
Cancel